Postmenopausal women with low BMD: Exercise or bisphosphonates?
09 Dec 2021
Postmenopausal women with low bone mass are encouraged to participate in bone-loading exercises and maintain adequate intake of calcium and vitamin D (CaD), while the addition of risedronate along with CaD can significantly improve BMD, particularly at the spine — such are the key messages of a recent study.
The Role of NOAC in Pandemic Era (TREND)
07 Dec 2021;
At a Pfizer-sponsored Masterclass, four distinguished speakers shared their insights into the role of NOACs in the management of NVAF and VTE, with a focus on apixaban (Eliquis®, Pfizer). Furthermore, the speakers discussed a stepwise approach to guide treatment choice amid the COVID-19 pandemic.
Indications/Uses : Advanced renal cell carcinoma in treatment-naive adults w/ intermediate or poor risk; adults following prior vascular endothelial growth factor-targeted therapy. Monotherapy for hepatocellular carcinoma in adults who have previously been treated w/ sorafenib.
Indications/Uses : Control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis, or chronic kidney disease (CKD) not on dialysis w/ serum P ≥1.78 mmol/L.
Indications/Uses : Monotherapy or in combination w/ methotrexate for moderate to severe active RA & active psoriatic arthritis in adult patients who have responded inadequately to or are intolerant to ≥1 disease-modifying anti-rheumatic drugs (DMARDs).
Manage Account
Change Password
Sign Out
